It has been identified as an emerging biomarker and potential therapeutic target in various types of human cancers.16 In this study, we demonstrated the vital role of FSCN1 in modulating cartilage homeostasis and suggested that targeted inhibition of FSCN1 could serve as a novel potential therapeutic approach for OA. Here, FSCN1 is linked to cancer.